medigraphic.com

2002, Number 3

<< Back Next >>

Med Sur 2002; 9 (3)

Type 2 diabetes mellitus prevention

Tamayo RRV

Language: Spanish
References: 11
Page: 115-118
PDF size: 35.94 Kb.


ABSTRACT

Type 2 diabetes mellitus is one of the most frequent degenerative diseases in Mexico. With an increase in obesity and sedentary lifestyle, it would be expected that in the next years an increase in diabetes should be observed. It is necessary to know about interventions to prevent or delay type 2 diabetes. There have benne made clinical trials about this issue. In this paper, 5 trials will be commented with their most important data and their conclusions. The commented trials are: the Da Qing study, the Finnish Diabetes Prevention Study, the Diabetes Prevention Program, the STOP-NIDDM Trial and the TRIPOD Study.


REFERENCES

  1. Ríos-Torres JUL, Rull JA. Epidemiología de la diabetes tipo 2 en México. En: Gómez Pérez, EJ. Avances en Diabetes. México, Corporativo Intermédica 1999: 43.

  2. American Diabetes Association and National Institute of Diabetes, Digestive and Kidney Diseases: The prevention or delay of Type 2 Diabetes. Diabetes Care 2002; 2925(4): 742-749.

  3. Pan X, Li G, Hu Y et al. Effects of diet and exercise in preventing NIDDM in people with impaired glucose tolerance. The Da Qing IGT and Diabetes Study. Diabetes Care 1997; 20(4): 537-544.

  4. Tuomilehto J, Lindström J, Eriksson J et al. Prevention of type 2 diabetes mellitus by changes in lifestyle among subjects with impaired glucose tolerance. NEJM 2001; 344(18): 1343-1350.

  5. Diabetes Prevention Program Research Group: Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin. NEJM 2002; 346(6): 393-403.

  6. Chiasson J, Josse R, Gomis R et al. Acarbose for prevention of type 2 diabetes mellitus: the STOP-NIDDM randomized trial. Lancet 2002; 359: 2072-2077.

  7. Berkowitz K, Peters R, Kjos S et al. Effect of troglitazone on insulin sensitivity and pancreatic B-cell function in women at high risk fon non-insulin dependent diabetes mellitus. Diabetes 1996; 45: 1572-1579.

  8. Azen S, Berkowitz K, Kjos S et al. A randomized placebo controlled trial of troglitazone in women with prior gestation diabetes mellitus. Controlled Clinical Trials 1998; 19: 217-231.

  9. Hernández-Jiménez S, Aguilar-Salinas C, Gómez-Pérez F. Tiazolidinedionas: Beneficios y riesgos reales. Revista de Endocrinología y Nutrición 2002; 10(2): 69-76.

  10. Pinkney J. Prevention and cure of type 2 diabetes. BMJ 2002; 325: 232-233.

  11. Franz M. The answer to weight loss is easy-Doing it is hard! Clinical Diabetes 2001; 19(3): 105-109.




2020     |     www.medigraphic.com